Highlights and Quick Summary
- Selling, General and Administrative Expense of Revenue for the quarter ending December 31, 2022 was -22.72% (a -137.48% decrease compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative Expense of Revenue decreased by -137.17%
- Annual Selling, General and Administrative Expense of Revenue for 2022 was 178.4% (a -51.05% decrease from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2021 was 364.44% (a 60.38% increase from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2020 was 227.23% (a 109.0% increase from previous year)
- Twelve month Selling, General and Administrative Expense of Revenue ending December 31, 2022 was 178.4% (a 22.87% increase compared to previous quarter)
- Twelve month trailing Selling, General and Administrative Expense of Revenue decreased by -26.51% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| 178.4% | 145.19% | 242.34% | 242.77% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative Expense of Revenue of Precigen, Inc.
Most recent Selling, General and Administrative Expense of Revenueof PGEN including historical data for past 10 years.Interactive Chart of Selling, General and Administrative Expense of Revenue of Precigen, Inc.
Precigen, Inc. Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -22.72% | 60.62% | 435.25% | 61.13% | 178.4% |
| 2021 | -42.32% | 329.34% | 391.98% | 76.3% | 364.44% |
| 2020 | -21.27% | 94.6% | 58.73% | 72.01% | 227.23% |
| 2019 | 153.79% | 121.25% | 58.62% | 137.48% | 108.72% |
| 2018 | 36.37% | 119.29% | 76.04% | 100.18% | 82.79% |
| 2017 | 26.7% | 85.36% | 71.36% | 65.38% | 59.55% |
| 2016 | 76.87% | 69.03% | 57.64% | 98.72% | 74.54% |
| 2015 | 83.71% | 43.13% | 52.73% | 81.62% | 62.82% |
| 2014 | 63.61% | 70.07% | 130.5% | 173.61% | 88.49% |
| 2013 | 172.15% | 122.59% | 111.12% | 166.8% | 141.49% |
| 2012 | 172.51% | 232.32% | – | – | 180.75% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology